- Home
- INBK vs NTHI Comparison
INBK vs NTHI Comparison
Compare INBK & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- NTHI
- Stock Information
- Founded
- INBK 1999
- NTHI 2008
- Country
- INBK United States
- NTHI United States
- Employees
- INBK N/A
- NTHI N/A
- Industry
- INBK Major Banks
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- NTHI Health Care
- Exchange
- INBK Nasdaq
- NTHI Nasdaq
- Market Cap
- INBK 190.0M
- NTHI 195.5M
- IPO Year
- INBK N/A
- NTHI N/A
- Fundamental
- Price
- INBK $17.95
- NTHI $9.26
- Analyst Decision
- INBK Hold
- NTHI
- Analyst Count
- INBK 3
- NTHI 0
- Target Price
- INBK $28.67
- NTHI N/A
- AVG Volume (30 Days)
- INBK 85.5K
- NTHI 56.4K
- Earning Date
- INBK 10-22-2025
- NTHI 12-18-2025
- Dividend Yield
- INBK 1.33%
- NTHI N/A
- EPS Growth
- INBK N/A
- NTHI N/A
- EPS
- INBK N/A
- NTHI N/A
- Revenue
- INBK $46,731,000.00
- NTHI $59,990.00
- Revenue This Year
- INBK $4.47
- NTHI N/A
- Revenue Next Year
- INBK $25.08
- NTHI N/A
- P/E Ratio
- INBK N/A
- NTHI N/A
- Revenue Growth
- INBK N/A
- NTHI N/A
- 52 Week Low
- INBK $17.30
- NTHI $3.20
- 52 Week High
- INBK $43.27
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- INBK 35.33
- NTHI N/A
- Support Level
- INBK $17.30
- NTHI N/A
- Resistance Level
- INBK $18.59
- NTHI N/A
- Average True Range (ATR)
- INBK 0.74
- NTHI 0.00
- MACD
- INBK 0.13
- NTHI 0.00
- Stochastic Oscillator
- INBK 32.56
- NTHI 0.00
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).